bluebird bio, Inc. Proceeds from Stock Options Exercised
bluebird bio, Inc. reported Proceeds from Stock Options Exercised of $16.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2023-03-29
- bluebird bio, Inc. proceeds from stock options exercised for the quarter ending 2020-03-31 was $963.00K, a 90.58% decline year-over-year.
- bluebird bio, Inc. proceeds from stock options exercised for the quarter ending 2019-12-31 was $2.00M, a 9.23% decline year-over-year.
- bluebird bio, Inc. proceeds from stock options exercised for the quarter ending 2019-09-30 was $4.18M, a 6.42% increase year-over-year.
- bluebird bio, Inc. proceeds from stock options exercised for the quarter ending 2019-06-30 was $4.78M, a 15.23% decline year-over-year.
- bluebird bio, Inc. proceeds from stock options exercised for fiscal 2022 was $16.00K, a 99.70% decline from fiscal 2021.
- bluebird bio, Inc. proceeds from stock options exercised for fiscal 2021 was $5.36M, a 3.40% increase from fiscal 2020.
- bluebird bio, Inc. proceeds from stock options exercised for fiscal 2020 was $5.18M, a 75.56% decline from fiscal 2019.
- bluebird bio, Inc. proceeds from stock options exercised for fiscal 2019 was $21.19M, a 33.29% decline from fiscal 2018.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2022-12-31 | $16.00K 10-K · filed 2023-03-29 | |||
| 2021-12-31 | $5.36M 10-K · filed 2023-03-29 | |||
| 2020-12-31 | $5.18M 10-K · filed 2023-03-29 | |||
| 2020-03-31 | $963.00K 10-Q · filed 2020-05-11 | $2.97M derived: sum of 2 quarters · filed 2022-03-04 | $7.15M derived: sum of 3 quarters · filed 2022-03-04 | $11.93M derived: sum of 4 quarters · filed 2022-03-04 |
| 2019-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | $6.18M derived: sum of 2 quarters · filed 2022-03-04 | $10.96M derived: sum of 3 quarters · filed 2022-03-04 | $21.19M 10-K · filed 2022-03-04 |
| 2019-09-30 | $4.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $8.96M derived: sum of 2 quarters · filed 2019-10-31 | $19.18M 10-Q · filed 2019-10-31 | $21.39M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-06-30 | $4.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $15.00M 10-Q · filed 2019-08-01 | $17.21M derived: sum of 3 quarters · filed 2021-02-23 | $21.14M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-03-31 | $10.22M 10-Q · filed 2020-05-11 | $12.43M derived: sum of 2 quarters · filed 2021-02-23 | $16.36M derived: sum of 3 quarters · filed 2021-02-23 | $22.00M derived: sum of 4 quarters · filed 2021-02-23 |
| 2018-12-31 | $2.21M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $6.13M derived: sum of 2 quarters · filed 2021-02-23 | $11.78M derived: sum of 3 quarters · filed 2021-02-23 | $31.76M 10-K · filed 2021-02-23 |
| 2018-09-30 | $3.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $9.57M derived: sum of 2 quarters · filed 2019-10-31 | $29.55M 10-Q · filed 2019-10-31 | |
| 2018-06-30 | $5.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $25.62M 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | $19.98M 10-Q · filed 2019-05-03 | |||
| 2017-12-31 | $33.23M 10-K · filed 2020-02-18 | |||
| 2016-12-31 | $6.93M 10-K · filed 2019-02-21 | |||
| 2014-06-30 | $1.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | $1.90M 10-Q · filed 2014-08-12 | $2.18M derived: sum of 3 quarters · filed 2014-08-12 | $2.21M derived: sum of 4 quarters · filed 2014-08-12 |
| 2014-03-31 | $671.00K 10-Q · filed 2014-05-13 | $955.00K derived: sum of 2 quarters · filed 2014-05-13 | $982.00K derived: sum of 3 quarters · filed 2014-05-13 | $1.01M derived: sum of 4 quarters · filed 2014-08-12 |
| 2013-12-31 | $284.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-05 | $311.00K derived: sum of 2 quarters · filed 2014-03-05 | $342.00K derived: sum of 3 quarters · filed 2014-08-12 | $376.00K 10-K · filed 2014-03-05 |
| 2013-09-30 | $27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $58.00K derived: sum of 2 quarters · filed 2014-08-12 | $92.00K 10-Q · filed 2013-11-14 | $105.00K derived: sum of 4 quarters · filed 2014-08-12 |
| 2013-06-30 | $31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | $65.00K 10-Q · filed 2014-08-12 | $78.00K derived: sum of 3 quarters · filed 2014-08-12 | $78.00K derived: sum of 4 quarters · filed 2014-08-12 |
| 2013-03-31 | $34.00K 10-Q · filed 2014-05-13 | $47.00K derived: sum of 2 quarters · filed 2014-05-13 | $47.00K derived: sum of 3 quarters · filed 2014-05-13 | |
| 2012-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-05 | $13.00K derived: sum of 2 quarters · filed 2014-03-05 | $21.00K 10-K · filed 2014-03-05 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $8.00K 10-Q · filed 2013-11-14 | ||
| 2012-06-30 | $8.00K 10-Q · filed 2013-08-14 | |||
| 2011-12-31 | $1.00K 10-K · filed 2014-03-05 |